CVCI invests $20m. into Aviv Ventures II

Aviv Venture Capital invests in Israel-related companies in the automotive, cleantech, consumer products, and medical device areas.

By SHARON WROBEL
August 23, 2007 07:40

Citi Venture Capital International, Citigroup's private investment arm focusing in growth markets, has committed to inject up to $20 million in Aviv Ventures II, a venture capital fund that targets mid-to late-stage technology investments in Israel. Aviv II has a target capitalization of $100m. and is expected to have its initial closing at $50m. Aviv Venture Capital invests in Israel-related companies in the automotive, cleantech, consumer products, and medical device areas.


Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS